We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$13.8B
AUM Growth
+$1.18B
Cap. Flow
+$317M
Cap. Flow %
2.3%
Top 10 Hldgs %
23.89%
Holding
1,675
New
92
Increased
753
Reduced
716
Closed
103

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16.8M
2
IBM icon
IBM
IBM
+$10.2M
3
ANSS
Ansys
ANSS
+$8.94M
4
QCOM icon
Qualcomm
QCOM
+$7.56M
5
TSLA icon
Tesla
TSLA
+$6.76M

Sector Composition

Rank Sector Weight
1 Technology 29.82%
2 Consumer Discretionary 8.62%
3 Communication Services 8.47%
4 Healthcare 7.28%
5 Financials 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JHG
1101
DELISTED
Janus Henderson
JHG
$611K ﹤0.01%
13,734
+1,716
+14% +$74.1K
NFG icon
1102
National Fuel Gas
NFG
$7.65B
$611K ﹤0.01%
6,616
-4,694
-42% -$409K
BNL icon
1103
Broadstone Net Lease
BNL
$4.02B
$606K ﹤0.01%
33,938
+151
+0.4% +$2.6K
HQH
1104
abrdn Healthcare Investors
HQH
$1.32B
$606K ﹤0.01%
32,819
-13,502
-29% -$221K
DYN icon
1105
Dyne Therapeutics
DYN
$4.9B
$603K ﹤0.01%
47,680
+7,059
+17% +$80.5K
PEN icon
1106
Penumbra
PEN
$12.8B
$602K ﹤0.01%
2,377
-41
-2% -$10.3K
TECH icon
1107
Bio-Techne
TECH
$11.3B
$600K ﹤0.01%
10,793
+503
+5% +$26.9K
IFF icon
1108
International Flavors & Fragrances
IFF
$21.9B
$597K ﹤0.01%
9,696
+1,349
+16% +$92.7K
SNAP icon
1109
Snap
SNAP
$9.01B
$596K ﹤0.01%
77,366
+26,787
+53% +$222K
SITM icon
1110
SiTime
SITM
$21.8B
$596K ﹤0.01%
1,978
-360
-15% -$83.5K
STX icon
1111
Seagate
STX
$184B
$596K ﹤0.01%
2,523
-1,727
-41% -$295K
TSCO icon
1112
Tractor Supply
TSCO
$18B
$595K ﹤0.01%
10,458
+444
+4% +$26.2K
KBR icon
1113
KBR
KBR
$4.8B
$595K ﹤0.01%
12,572
+182
+1% +$8.83K
ALGM icon
1114
Allegro MicroSystems
ALGM
$8.16B
$591K ﹤0.01%
20,234
+1,533
+8% +$49.6K
HTGC icon
1115
Hercules Capital
HTGC
$3.23B
$590K ﹤0.01%
31,204
-161
-0.5% -$3.09K
HOG icon
1116
Harley-Davidson
HOG
$2.71B
$589K ﹤0.01%
21,124
+829
+4% +$22.2K
CLDX icon
1117
Celldex Therapeutics
CLDX
$3.28B
$588K ﹤0.01%
22,721
-3,274
-13% -$75.9K
CE icon
1118
Celanese
CE
$4.82B
$584K ﹤0.01%
13,874
+715
+5% +$35.6K
PPC icon
1119
Pilgrim's Pride
PPC
$6.54B
$583K ﹤0.01%
14,320
+81
+0.6% +$3.67K
SEE
1120
DELISTED
Sealed Air
SEE
$583K ﹤0.01%
16,495
+400
+2% +$12.8K
FMS icon
1121
Fresenius Medical Care
FMS
$12.9B
$581K ﹤0.01%
22,062
-589
-3% -$15.1K
S icon
1122
SentinelOne
S
$7.34B
$579K ﹤0.01%
32,899
-400
-1% -$7.17K
ESTC icon
1123
Elastic
ESTC
$7.81B
$577K ﹤0.01%
6,835
-83
-1% -$6.99K
NVAX icon
1124
Novavax
NVAX
$1.31B
$575K ﹤0.01%
66,358
-5,011
-7% -$39K
VTIP icon
1125
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$573K ﹤0.01%
11,324
-8,903
-44% -$448K

Similar funds

Guggenheim Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Guggenheim Capital held 1,675 positions worth $13.8B, up 9.4% from $12.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Guggenheim Capital's Q3 2025 filing shows 92 new, 753 increased, 716 reduced and 103 closed positions. Its largest new stake was Thomson Reuters: 100,588 shares worth $15.9M. The largest sale was NVIDIA, an estimated $16.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Guggenheim Capital's largest Q3 2025 buy was Thomson Reuters: 100,588 shares worth $15.9M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $48.1M increase.
  • Guggenheim Capital's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $16.8M.
  • Guggenheim Capital fully exited Ansys in Q3 2025, selling an estimated $8.94M.
  • Guggenheim Capital's ten largest holdings make up 24% of its $13.8B portfolio in Q3 2025.
  • Guggenheim Capital opened 92 new positions and closed 103 in Q3 2025.
  • Guggenheim Capital's portfolio value rose 9.4% quarter-over-quarter to $13.8B.

Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.